# Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

> **NCT04675255** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 8 (actual)

## Conditions studied

- HIV I Infection
- Adiposity

## Interventions

- **PROCEDURE:** Frequently sampled glucose tolerance testing
- **PROCEDURE:** abdominal subcutaneous adipose tissue biopsy
- **PROCEDURE:** MRI scan to assess intrahepatic triglyceride content

## Key facts

- **NCT ID:** NCT04675255
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-06-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04675255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04675255, "Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04675255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*